Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Davis H. L., Bailey D. G., Johnson G. E., Wilson T. W. The necessity of drug level monitoring in anticonvulsant drug therapy. Can J Physiol Pharmacol. 1976 Dec;54(6):850–858. doi: 10.1139/y76-119. [DOI] [PubMed] [Google Scholar]
- Kutt H., Haynes J., McDowell F. Some causes of ineffectiveness of diphenylhydantoin. Arch Neurol. 1966 May;14(5):489–492. doi: 10.1001/archneur.1966.00470110033004. [DOI] [PubMed] [Google Scholar]
- Livingston S., Berman W. Checking compliance of epileptic patients. N Engl J Med. 1972 Nov 2;287(18):934–934. doi: 10.1056/nejm197211022871818. [DOI] [PubMed] [Google Scholar]
- Lund L. Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalized epileptic seizures. Arch Neurol. 1974 Nov;31(5):289–294. doi: 10.1001/archneur.1974.00490410037002. [DOI] [PubMed] [Google Scholar]
- Lund M. Failure to observe dosage instructions in patients with epilepsy. The short-term effect of a daily dispenser. Acta Neurol Scand. 1973;49(3):295–306. doi: 10.1111/j.1600-0404.1973.tb01302.x. [DOI] [PubMed] [Google Scholar]
- Reynolds E. H., Shorvon S. D. Monotherapy or polytherapy for epilepsy? Epilepsia. 1981 Feb;22(1):1–10. doi: 10.1111/j.1528-1157.1981.tb04327.x. [DOI] [PubMed] [Google Scholar]
- Shorvon S. D., Chadwick D., Galbraith A. W., Reynolds E. H. One drug for epilepsy. Br Med J. 1978 Feb 25;1(6111):474–476. doi: 10.1136/bmj.1.6111.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shorvon S. D., Reynolds E. H. Reduction in polypharmacy for epilepsy. Br Med J. 1979 Oct 27;2(6197):1023–1025. doi: 10.1136/bmj.2.6197.1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
